We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Biosimilars Create Competition, Savings in EU Markets
Biosimilars Create Competition, Savings in EU Markets
Biosimilars consistently drive down average drug prices in markets where they are introduced, according to a report ordered by the European Commission.
To View This Article:
Login
Subscribe To International Pharmaceutical Regulatory Monitor